<unk>  is a calcium-sensing receptor agonist that is FDA approved for the {{{indicationType}}} of secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) on dialysis, hypercalcemia in patients with parathyroid carcinoma, severe hypercalcemia in patients with primary HPT who are unable to undergo parathyroidectomy.   Common adverse reactions include nausea, vomiting, and diarrhea.
Cinacalcet
Carbasalate calcium
Elagolix
Meclizine
Naloxegol
Tyramine
Crofelemer
Xaliproden